Tag: South Korea

The finished medicinal product market of South Korea shows significant growth

South Korea's pharmaceutical market is experiencing significant growth in finished drug products, according to CPhI Korea.

Global biotech conference started in South Korea

The 2018 Global Bio Conference kicked off in Seoul, bringing together biotech regulators and industry experts from around the world to support the growth and overseas expansion of South Korea’s biopharmaceutical businesses.

Pharma Research Products gains a generic botulinum toxin production company

Pharma Research Products Company Ltd. (PRP) a Korean company engaged in the development of medical esthetic products, secured majority ownership of botulinum toxin type A injection production facility of BioCND.

Samsung BioLogics is concerned about the accusation of accounting fraud

samsung biologics
South Korea’s major biopharmaceutical firm Samsung BioLogics Co., which has been embroiled in an alleged violation of accounting rules, expressed concern over the local financial regulator’s disclosure of sensitive information.

South Korea will support AI drug development

drug discovery
South Korea’s largest biopharmaceutical business association has kickstarted preparations for a support center that will leverage artificial intelligence to help pharmaceutical companies accelerate new drug development processes

South Korea doubles its investments in the pharmaceutical sector

South Korea pledged to double its investments in the pharmaceutical sector to help develop 15 new drugs in the next five years